Adiro 100 mg comprimidos gastrorresistentes EFG

DRUG3 trials

Sponsors

Fundacion Biomedica Galicia Sur, Fundacion Epic

Conditions

Acute coronary syndromeDegree of control coronary risk factors and platelet aggregationSevere Symptomatic Aortic Stenosis

Phase 3

CROSS-OVER ANALYSIS OF THE CONTROL OF RISK FACTORS AND ANTIAGGREGATION WITH POLIPILL (POLICROSS TRIAL)

Not yet recruitingCTIS2024-518705-18-00

Fundacion EpicDegree of control coronary risk factors and platelet aggregation

Target: 88Updated: 2024-11-04

Phase 4

Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical trial

RecruitingCTIS2023-509290-22-00

Fundacion Biomedica Galicia SurSevere Symptomatic Aortic Stenosis

Start: 2022-01-21Target: 1200Updated: 2025-09-16

Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a randomized study

Not yet recruitingCTIS2025-524751-32-00

Fundacion EpicAcute coronary syndrome

Target: 216Updated: 2026-03-30